NeuroImmunoModulation

eISSN: 1423-0216pISSN: 1021-7401

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
4.1
Impact Factor
< 5
SNIP
0.68

Journal Specifications

Indexed in the following public directories

  • Web of Science
  • Scopus
  • SJR
Overview
  • Publisher
    KARGER
  • Language
    English
  • Frequency
    Quarterly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

check-iconMeets Top Publisher Standards: Essential for leading journals like Elsevier.
check-iconEnhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
check-iconTailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn morethumb-icon 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Peripheral blood
Brain development
Lipopolysaccharide
Cognitive impairment
Interleukin
Western blot
Microglia
Multiple sclerosis
Brain-derived neurotrophic factor
Major depressive disorder
Nitric oxide
Spinal cord
Emotion perception
Severe acute respiratory syndrome coronavirus
Intracerebral hemorrhage
Central nervous system
Cerebrospinal fluid
Disease severity
Inflammation
Transverse myelitis

Year-wise Publication

FAQs

Since when has NeuroImmunoModulation been publishing? Faqs

The NeuroImmunoModulation has been publishing since 1994 till date.

How frequently is the NeuroImmunoModulation published? Faqs

NeuroImmunoModulation is published Quarterly.

Who is the publisher of NeuroImmunoModulation? Faqs

The publisher of NeuroImmunoModulation is KARGER.

How can I view the journal metrics of NeuroImmunoModulation on editage? Faqs

For the NeuroImmunoModulation metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of NeuroImmunoModulation? Faqs

The eISSN number is 1423-0216 and pISSN number is 1021-7401 for NeuroImmunoModulation.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Peripheral blood, Brain development, Lipopolysaccharide, Cognitive impairment, Interleukin, Western blot, Microglia, Multiple sclerosis, Brain-derived neurotrophic factor, Major depressive disorder, Nitric oxide, Spinal cord, Emotion perception, Severe acute respiratory syndrome coronavirus, Intracerebral hemorrhage, Central nervous system, Cerebrospinal fluid, Disease severity, Inflammation, Transverse myelitis.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.